Laubscher, G.J.; Lourens, P.J.; Venter, C.; Kell, D.B.; Pretorius, E.
TEG®, Microclot and Platelet Mapping for Guiding Early Management of Severe COVID-19 Coagulopathy. J. Clin. Med. 2021, 10, 5381.
https://doi.org/10.3390/jcm10225381
AMA Style
Laubscher GJ, Lourens PJ, Venter C, Kell DB, Pretorius E.
TEG®, Microclot and Platelet Mapping for Guiding Early Management of Severe COVID-19 Coagulopathy. Journal of Clinical Medicine. 2021; 10(22):5381.
https://doi.org/10.3390/jcm10225381
Chicago/Turabian Style
Laubscher, Gert Jacobus, Petrus Johannes Lourens, Chantelle Venter, Douglas B Kell, and Etheresia Pretorius.
2021. "TEG®, Microclot and Platelet Mapping for Guiding Early Management of Severe COVID-19 Coagulopathy" Journal of Clinical Medicine 10, no. 22: 5381.
https://doi.org/10.3390/jcm10225381
APA Style
Laubscher, G. J., Lourens, P. J., Venter, C., Kell, D. B., & Pretorius, E.
(2021). TEG®, Microclot and Platelet Mapping for Guiding Early Management of Severe COVID-19 Coagulopathy. Journal of Clinical Medicine, 10(22), 5381.
https://doi.org/10.3390/jcm10225381